Abstract
To discuss the effect of continuous blood purification (CBP) on the prognosis of cardiorenal syndrome (CRS) patients. Twenty-seven patients were selected for this study, who had previously been treated at the Blood Purification Center of the General Hospital of Jinan Military Region from May 2007 to October 2010. All patients suffered from chronic heart failure and acute kidney injury. Using a non-invasive hemodynamics monitoring system, we observed the dynamic changes in their cardiac output (CO), systemic vascular resistance (SVR), thoracic fluid capacity (TFC), central venous pressure (CVP), urinary volume, and Acute Physiology and Chronic Health Evaluation II system (APACHEII) score. Individual measurements were obtained at 24 h, 48 h, 72 h, 96 h, and 120 h after CBP treatment. At the same time, levels of serum creatinine (Scr), cysteine proteinase inhibitor Cystatin C (CysC), high sensitivity C-reactive protein (hs-CRP), and serum sodium were observed. The fatality rate at 28 days was also recorded. After 24 h of CBP treatment, acidosis, CO, and disturbances in water and electrolyte levels were all improved. As well, concentrations of Scr and CysC were significantly decreased, and the levels of SVR, TFC, and CVP were also decreased. After 72 h of CBP treatment, hs-CRP levels and APACHE II scores were significantly lower (P < 0.01). From 72 to 120 h of CBP treatment, oliguria was resolved in 24 patients, with improved sensitivity to diuretics. The fatality rate at 28 days was 11.12 %. CBP treatment could improve myocardial function, shorten the oliguria period, decrease the fatality rate, and improve the prognosis of CRS patients.
Similar content being viewed by others
References
Du, Y., Li, X., & Liu, B. (2014). Advances in pathogenesis and current therapeutic strategies for CRS. Life Sciences, 99(1–2), 1–6.
Kociol, R., Rogers, J., & Shaw, A. (2009). Organ cross talk in the critically ill: the heart and kidney. Blood Purification, 27(4), 311–320.
Lindner, G., Doberer, E., Vychytil, A., et al. (2009). Prognosis in patients with congestive heart failure and subacute renal failure treated with hemodialysis. Wiener klinische Wochenschrift, 121(11–12), 391–397.
Li, X., Mao, H., Yu, X., et al. (2014). Prognostic factors in continuous hemofiltration therapy for patients with CRS. Blood Purification, 37(2), 99–105.
Ricci, Z., & Ronco, C. (2012). Renal replacement therapy in the critically ill:getting it right. Current Opinion in Critical Care, 18(6), 607–612.
Lee, P. T., Lin, H. H., Jiang, S. T., et al. (2010). Mouse kidney progenitor cells accelerate renal regeneration and prolong survival after ischemic injury. Stem Cells, 28(3), 573–584.
Dunlay, S. M., Pereira, N. L., & Kushwaha, S. S. (2014). Contemporary strategies in the diagnosis and management of heart failure. Mayo Clinic Proceedings, 89(5), 662–676.
Ronco, C. (2005). Acute Dialysis Quality Initiative (ADQI): the PASSPORT project. International Journal of Artificial Organs, 28(5), 438–440.
Fieghen, H., Wald, R., & Jaber, B. L. (2009). Renal replacement therapy for AKI. Nephron Clinical Practice, 112(4), c222–c229.
Ronco, C., Chionh, C. Y., Haapio, M., Anavekar, N. S., House, A., & Bellomo, R. (2009). The cardiorenal syndrome. Blood Purification, 27(1), 114–126.
Shlipak, M. G. (2003). Pharmacotherapy for heart failure in patients with renal insufficiency. Annals of Internal Medicine, 138(11), 917–924.
Jarnberg, P. O. (2004). Renal protection strategies in the perioperative period. Best Practice & Research Clinical Anaesthesiology, 18(4), 645–660.
Wago, M., & Shimooka, T. (2011). Extracorporeal blood purification (renal replacement therapy). Nihon Rinsho, 69(3), 534–540.
Kaltenmaier, B., Pommer, W., Kaufmann, F., Hennig, E., Molzahn, M., & Hetzer, R. (2000). Outcome of patients with ventricular assist devices and acute renal failure requiring renal replacement therapy. ASAIO Journal, 46(3), 330–333.
Jang, H. R., Gandolfo, M. T., Ko, G. J., Satpute, S. R., Racusen, L., & Rabb, H. (2010). B cells limit repair after ischemic AKI. Journal of the American Society of Nephrology, 21(4), 654–665.
Conflict of interest
Authors claim to have no financial conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jia, F., Rong, P., Li, D. et al. The Effect of Continuous Blood Purification on the Prognosis of Cardiorenal Syndrome Patients. Cell Biochem Biophys 71, 957–961 (2015). https://doi.org/10.1007/s12013-014-0293-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12013-014-0293-x